MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2019 International Congress

September 22-26, 2019. Nice, France.

View by Title View Sessions
View by Date

Monday, September 23, 2019

1:45pm-3:15pm
Neurofascin is a novel gene associated with autosomal recessive spastic and polyneuropathy

L. Straniero, E. Monfrini, S. Bonato, G. Monzio Compagnoni, A. Bordoni, R. Dilena, R. Silipigni, D. Ronchi, S. Duga, A. Di Fonzo (Pieve Emanuele, Milan, Italy)

Genetics  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Neurological Wilson Disease: Clinical Aspects and Evolution in 10 Cases

Y. Mecheri, F. Serradj, A. Boulefkhad, H. Semra, A. Mzahem, A. Hamri, Y. Sifi (Constantine, Algeria)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Neuromelanin MRI detects monoaminergic cell loss in Huntington Disease Expansion Gene Carriers.

ER. de Natale, H. Wilson, G. Dervenoulas, F. Niccolini, SJ. Tabrizi, M. Politis (London, United Kingdom)

Huntington’s Disease  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Neuropathological findings in a SPG4 gene mutation carrier

S. Forcén, I. Aldecoa, AM. Crespo, O. Ramos, L. Ispierto, R. álvarez, D. Vilas (Badalona, Spain)

Other  ·  Agora 2 West, Level 2
1:45pm-3:15pm
Neuropathology in a case of HD-like syndrome caused by mutations in RNF216

P. Santens, A. Sieben, B. Dermaut (Ghent, Belgium)

Rare Genetic and Metabolic Diseases  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Neuroprotective and neurotrophic efficacy of Ginkgo biloba extracts against 3-nitropropionic acid-induced oxidative stress in a rat model of Huntington’s disease

P. Kashyap, S. Gupta (Darbhanga, India)

Huntington’s Disease  ·  Agora 3 West, Level 3
1:45pm-3:15pm
Neuropsychiatric clusters in patients with Parkinson’s disease and their clinical and demographic correlates

M. Sommerauer, C. Schedlich-Teufer, P. Reker, E. Kalbe, J. Kessler, M. Barbe (Köln, Germany)

Psychiatric Manifestations  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Neuropsychiatric manifestations in Parkinson’s disease

O. Cherkaoui Rhazouani, N. Jalami, M. Chraa, N. Kissani (Marrakech, Morocco)

Psychiatric Manifestations  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Neuropsychological and behavioral profile of patients with isolated REM sleep behaviour disorders (iRBD) and patients with RBD associated with Parkinson’s Disease (PDRBD)

M. Figorilli, P. Pisanu, MG. Mascia, M. Meloni, RM. Lecca, G. Gioi, P. Congiu, L. Tamburrino, G. Defazio, M. Fantini, M. Puligheddu (Monserrato, Italy)

Restless Leg Syndrome, RBD and Other Sleep Disorders  ·  Les Muses Terrace, Level 3
1:45pm-3:15pm
Neuropsychological profile of patients with functional movement disorders

G. Vechetova, T. Nikolai, M. Slovak, Z. Hanzlikova, M. Vranka, E. Bolcekova, T. Teodoro, E. Ruzicka, M. Edwards, T. Serranova (Prague, Czech Republic)

Functional (Psychogenic) Movement Disorders  ·  Les Muses Terrace, Level 3
  • «Previous Page
  • 1
  • …
  • 44
  • 45
  • 46
  • 47
  • 48
  • …
  • 75
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Patients with Essential Tremor Live Longer than their Relatives
  • #23624 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Three cases of early tremor in the course of Guillain-Barré Syndrome
  • The impact of gastric acid suppressants and antacids on levodopa plasma concentration in patients with Parkinson’s disease
  • To be or not to bupropion: a drug-induced parkinsonism?
  • The Role of MRI and DaTscan in Vascular Parkinsonism: A Case Report
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley